Encompass Health Corporation (EHC) — Analyst outlook / Analyst consensus target is. Based on 26 analyst ratings, the consensus is bullish — 1 Strong Buy, 20 Buy, 4 Hold, 1 Sell.
The consensus price target is $153.00, representing an upside of 43.4% from the current price $106.70.
Analysts estimate Earnings Per Share (EPS) of $4.30 and revenue of $5.35B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $4.56 vs est $4.30 (beat +6.1%). 2025: actual $5.63 vs est $5.31 (beat +6%). Analyst accuracy: 94%.
EHC Stock — 12-Month Price Forecast
$153.00
▲ +43.39% Upside
Average Price Target
Based on 26 Wall Street analysts offering 12-month price targets for Encompass Health Corporation, the price target is $153.00.
The average price target represents a +43.39% change from the last price of $106.70.
EHC Analyst Ratings
Buy
Based on 26 analysts giving stock ratings to Encompass Health Corporation in the past 3 months
EPS Estimates — EHC
94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $4.56
vs Est $4.30
▲ 5.7% off
2025
Actual $5.63
vs Est $5.31
▲ 5.7% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving.
Revenue Estimates — EHC
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $5.373B
vs Est $5.349B
▲ 0.4% off
2025
Actual $5.935B
vs Est $5.930B
▲ 0.1% off
Revenue Trend
Moderate revenue growth trend. Analysts expect stable revenue going forward.
